Connection

LOIS M RAMONDETTA to Neurofibromin 1

This is a "connection" page, showing publications LOIS M RAMONDETTA has written about Neurofibromin 1.
Connection Strength

0.045
  1. The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial. Invest New Drugs. 2021 06; 39(3):829-835.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.